A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Cyclin A/B-RxL Inhibitor CID-078 in Patients With Advanced Solid Tumor Malignancies

This study is testing a new experimental pill called CID-078 to see if it is safe and effective for patients with advanced solid tumors. It is a 'Phase 1' trial, which means researchers are primarily looking to learn how the drug works in the human body for the first time.

This trial is for adults 18 and older with advanced solid tumors, such as breast or lung cancer, that have not responded to or have worsened after standard treatments. You must have a tumor that can be measured by medical scans and meet specific genetic requirements to be considered.

If you join, you will take the experimental medication CID-078 as your primary treatment. The research team will closely monitor your health to see how your body reacts to the medication and check if it helps slow down or stop the growth of your cancer.

The study is currently recruiting volunteers at medical centers in Sarasota, Florida; Boston, Massachusetts; and Grand Rapids, Michigan. Because this is a clinical trial, you should discuss with your doctor whether traveling to one of these sites is feasible for you.